Home News Latest News HPRA Drug Safety Newsletter Edition 102

HPRA Drug Safety Newsletter Edition 102

Home News Latest News HPRA Drug Safety Newsletter Edition 102
March 23, 2021

The 102nd edition of the HPRA Drug Safety Newsletter includes information about the conclusion of the European Medicines Agency's (EMA) review of thromboembolic events following vaccination with Covid-19 Vaccine AstraZeneca.

The 102nd edition of the HPRA Drug Safety Newsletter includes information about the conclusion of the European Medicines Agency's (EMA) review of thromboembolic events following vaccination with Covid-19 Vaccine AstraZeneca.

The online versions of the DSN contains hyperlinks to product information and other documents on the HPRA and EMA websites, as appropriate.

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.